Temasek-backed Hangzhou Just Biotherapeutics closes $35m Series B+ round

Temasek-backed Hangzhou Just Biotherapeutics closes $35m Series B+ round

Photo: Bloomberg

Ka Kay Lum

07 June, 2018

Hangzhou Just Biotherapeutics Co LtdHillhouse Capital

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2026 All rights reserved.